Welcome to KBC Securities
We believe banking is a craft, not an art or a science. As the integrated Equity
House of KBC Group, we combine specialist expertise, skill and personal commitment
to bring lasting value to our clients and people.
More about us
Collapse research area
- Benelux Morning Note23 feb 2017
Ablynx: FY16 – No big surprises
Deceuninck: FY results slightly better than expected
Gimv: Further increase in portfolio and equity value
Heijmans: Final FY16 results, mixed picture for outlook
IBA: Wins Proteus one contr ...
- Benelux Morning Note22 feb 2017
Aedifica: Strong HY EPS beat – New equity coming soon
ASR: Delivering on its promises
BAM Group: Main topics discussed at FY16 analyst meeting
CFE: Financial close Hohe See offshore wind project
Fugro: Preview FY16
- Benelux Morning Note21 feb 2017
BAM Group: Solid FY16 results, strong on cash
Brunel International: 4Q16 preview
GrandVision: CC feedback & post-view changes
Montea: FY16 hit by IRS, Outlook in-line, Strong portfolio
Resilux: Is Petainer Bain’s other ta ...
- Benelux Morning Note20 feb 2017
Boskalis: Re-setting assets with € 840m impairment
CP Invest: Giant leap ahead with € 34m acquisition in BXL
GrandVision: Just in line with expectations
IBA: Wins Charleroi PT one contract
Kinepolis: Expect further steps ...
- Benelux Company Flash:Randstad: Growth at a cost, rating cut to Accumulate20 feb 2017
- Benelux Morning Note17 feb 2017
AEGON: Earnings beat but Solvency a bit below expectations
Akzo Nobel: Feedback analyst meeting
Arcadis: Main topics 4Q16 analyst meeting
Atenor: Third Vaci Greens office building sold
BAM Group: Preview 4Q16: Restoring c ...
- Benelux Morning Note16 feb 2017
Arcadis: 4Q16 below expectations, provision for receivables
Celyad: First blood cancer patient recruited in THINK
EVS: Better Q4 on margins, excellent orderbook
Heijmans: Heijmans secures financing, major FY16 ...
- CFE: Gone with the wind15 feb 2017
DEME provides strong visibility with a backlog approaching € 4bn, not yet including estimated workload of >€ 1bn. The EBITDA margin has reached historic highs and DEME’s 1H16 EBITDA margin of 23.1% again points to a strong ye ...